After a Point-Blank Rejection Letter from the FDA, Sprout Pharmaceuticals Founder Cindy Whitehead Had to Go Back to the Drawing Board

Cindy Whitehead spent years working on a treatment for low sexual desire in women. When the FDA rejected her drug, she disputed the decision with the stories of affected women — and won.